Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calmangafodipir Phase 3 Trial in Japan
jRCT2080224125Phase 3Terminated
- Start
- Nov 2018
- Modality
- Small Molecules
01
Overview
Phase 3 trial of calmangafodipir (2 arms). Started Nov 2018; status: terminated.
02
Drugs
calmangafodipir
Beyond the preview
Go deeper on jRCT2080224125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224125.